ModifiedUnitedHealthcarePolicy CS363.D

Interspinous Fusion and Decompression Devices

This policy governs coverage and medical necessity criteria for interspinous fixation (fusion) devices and interspinous decompression/interlaminar stabilization devices in the lumbar spine (L1-S1); it specifies when devices are considered proven/medically necessary versus unproven/not medically necessary.

Policy Summary

PayerUnitedHealthcare

PolicyInterspinous Fusion and Decompression Devices

Policy CodePolicy CS363.D

Change TypeDocumentation and definitional updatesevidence update

Effective DateJan 1, 2026

Next Review Date

Key ActionInclude the physician treatment plan with device type and level in medical records submitted for prior authorization reviews.

SourceLink

POLICY UPDATE CHANGES

Added 'physician treatment plan, including device type and level' to the list of medical records documentation used for reviews.

Removed requirement to 'describe the surgical technique(s) planned, including name of interspinous bony fusion device requested and use of an interbody cage'.

Updated definitions for Arthrodesis, Interlaminar Lumbar Instrumented Fusion (ILIF), Interlaminar Stabilization Device, and Neurogenic Claudication.

Updated clinical evidence and references and archived previous policy version CS363.C.

severalevidence sources summarized

reoperation ↑safety signal / outcome

no superioritycomparative effectiveness

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

evidence assessments

Grade 1max spondylolisthesis for devices

Coverage and Medical Necessity Criteria

Interspinous Fixation (fusion) - Medically Necessary

Interspinous fixation (fusion) devices are considered proven and medically necessary when ALL of the following are met:

Interspinous fixation device criteria: Performed according to FDA labeled indications, contraindications, warnings, and precautions.

Discogenic pain: Back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies.

Spondylolisthesis limit: No more than Grade I spondylolisthesis at the treated level.<= Grade I

Adjunct to fusion: Used with an interbody cage as an adjunct to fusion at a single lumbar level (L1–S1).single level

Interspinous Decompression / Interlaminar Stabilization - Not Medically Necessary

Interspinous decompression/interlaminar stabilization devices (without fusion):

Coverage stance: Considered unproven and not medically necessary for treatment of spine pain or spinal stenosis due to insufficient evidence of efficacy and uncertain long-term safety; additional large, well‑designed, long‑term trials are needed.

Clinical evidence limited; no demonstrated superiority to decompression and concerns about reoperation rates.

Coverage criteria for static interspinous distraction devices (without fusion)

Covered when ALL of the following are met for static interspinous distraction devices used instead of direct decompression:

Diagnosis: Clinically symptomatic degenerative lumbar stenosis with neurogenic claudication that is relieved by lumbar flexion.

NASS 2025

Functional thresholds: Sitting for at least 50 minutes without pain and able to walk at least 50 feet.sitting >= 50 minutes; walk >= 50 feet

NASS 2025

Imaging severity: Mild to moderate stenosis on CT or MRI defined as 25–50% reduction in lateral/central foraminal diameter compared to adjacent levels.25-50%

NASS 2025

Coverage context for interspinous fusion devices (with fusion)

Interspinous devices affixed to spinous processes for stabilization may be considered as an adjunct when used WITH lumbar fusion procedures if ALL of the following contextual conditions are met:

Indication: Utilized in the context of lumbar fusion for diagnoses such as stenosis, disc herniation, or synovial facet cyst where adjunct stabilization is appropriate.

NASS 2025

Surgical technique and fusion: Used in conjunction with robust open laminar and/or facet decortication and fusion and/or robust autograft inter‑ and extra‑spinous process decortication and fusion, and/or interbody fusion of the same motion segment.

NASS 2025

Facet joint adjunct: May be considered as adjunct to cyst excision when removal of >50% of the facet joint occurs.>50% facet removal

NASS 2025

Use of interspinous decompression and interlaminar stabilization systems without fusion for treatment of spine pain or lumbar spinal stenosis is listed as an exclusion in this policy. Interspinous fixation devices that are used to promote fusion and that meet FDA-labeled indications and the coverage criteria described for fusion (e.g., adjunct to interbody cage at a single lumbar level, L1–S1, and spondylolisthesis ≤ Grade 1) are addressed separately; however, standalone interspinous decompression or interlaminar stabilization implants without fusion are considered outside the scope of covered, medically necessary treatment.

Devices that affix to the spinous processes for posterior stabilization or fusion have specific anatomic and stability contraindications. They should not be used when there is degenerative spondylolisthesis > Grade 1, bilateral isthmic spondylolysis, significant dynamic instability (e.g., on flexion–extension views), scoliosis or coronal/rotatory instability, or when fusion is indicated at more than one lumbar level. These devices are generally not indicated at L5–S1 because of small S1 spinous processes unless the anatomy is favorable, and they are not appropriate when complete facet resection is required unless an interbody fusion accompanies the procedure.

Static interspinous distraction devices (implanted without direct decompression) are explicitly not indicated for patients who fall outside the NASS-defined qualifying criteria. Specific exclusions include: body mass index ≥ 40, a fixed motor deficit, prior lumbar surgery at the intended level, symptoms that are not relieved by lumbar flexion, degenerative scoliosis > 25°, or degenerative spondylolisthesis of Grade II or higher. These devices are also not appropriate when the patient is medically suitable for standard direct decompression such as laminectomy or when the primary problem is axial back pain unrelated to activity.

Interspinous decompression and interlaminar stabilization systems implanted without fusion are considered unproven and not medically necessary. This determination is based on insufficient high‑quality evidence of long‑term efficacy and unresolved safety concerns; available systematic reviews and evidence assessments indicate limited, low‑quality data and emphasize the need for larger, well‑designed trials before these devices can be considered established therapeutic alternatives to standard decompression or fusion.

Comparative effectiveness and safety data do not demonstrate consistent superiority of interspinous process devices over standard decompression. Multiple systematic reviews and meta‑analyses report no clear improvement in pain or function compared with decompression and identify a signal for higher reoperation rates in some studies. Evidence assessments characterize the overall evidence base as limited or low quality, and longer follow‑up and larger randomized trials are needed to clarify relative outcomes and safety.

Applicable Codes and Coding Guidance

Applicable CPT / Unlisted CodesCPT

22853	Insertion of interbody biomechanical device(s) (e.g., synthetic cage, mesh) with integral anterior instrumentation for device anchoring (e.g., screws, flanges), when performed, to intervertebral disc space in conjunction with interbody arthrodesis, each interspace (List separately in addition to code for primary procedure).
22854	Insertion of intervertebral biomechanical device(s) (e.g., synthetic cage, mesh) with integral anterior instrumentation for device anchoring (e.g., screws, flanges), when performed, to vertebral corpectomy(ies) (vertebral body resection, partial or complete) defect, in conjunction with interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure).
22859	Insertion of intervertebral biomechanical device(s) (e.g., synthetic cage, mesh, methylmethacrylate) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure).
22867	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; single level.
22868	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; second level (List separately in addition to code for primary procedure).
22869	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; single level.
22870	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; second level (List separately in addition to code for primary procedure).
22899	Unlisted procedure, spine [when specified as insertion of a non-pedicle interspinous process fixation device]

Device regulatory listings (informational)mixed

See FDA 510(k) listings

Various interspinous fusion and decompression devices have 510(k) marketing clearance; specific device product codes and listings available via FDA database. Refer to: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm.

Clinical imaging severity for static devices — definition of mild to moderate stenosis (25-50% reduction)

Imaging severityMild to moderate stenosis defined as 25-50% reduction in lateral/central foraminal diameter compared to adjacent levels

ModalityAssessment based on CT or MRI advanced imaging

Comparison referencePercent reduction compared to adjacent (unaffected) levels on the same study

Functional thresholds for neurogenic claudication — sitting and walking distance thresholds

Sitting thresholdSitting for at least 50 minutes without pain

Walking thresholdAble to walk at least 50 feet

Prior Authorization, Documentation, and Provider Guidance

Prior Authorization

Prior Authorization Required

Prior authorization may be required for interspinous device procedures. Check plan-specific prior authorization rules before scheduling; inability to obtain prior authorization when required may result in claim denial or member liability.

Prior authorization requirement may apply to insertion of interspinous/interlaminar devices (with or without decompression).
Verify authorization for planned device type and levels prior to procedure scheduling.

Documentation Required

Medical Records May Be Requested

Medical record documentation may be requested to determine whether the member meets clinical criteria for coverage. Submission of records does not guarantee coverage; services must meet the policy's medical necessity criteria.

Medical records may be requested to support medical necessity determinations.

Clinical Background and Rationale

Lumbar spinal stenosis (LSS) is a degenerative narrowing of the lumbar spinal canal or foramina that produces compression of neural elements and commonly manifests as leg and/or back pain with neurogenic claudication. Symptoms classically improve with lumbar flexion and worsen with extension. Surgical treatment options range from decompression alone (e.g., laminectomy) to decompression with instrumented fusion; interspinous implants span a spectrum from interspinous fixation devices used as adjuncts to fusion to interspinous decompression or interlaminar stabilization devices intended to provide indirect decompression. The policy differentiates these device types because interspinous fixation with fusion has defined, limited indications supported by FDA labeling and specific coverage criteria, whereas interspinous decompression/interlaminar stabilization devices without fusion lack sufficient evidence of long‑term efficacy and safety.

Key Definitions

Arthrodesis definition

DefinitionArthrodesis: surgical procedure to eliminate motion in a joint by providing a bony fusion (achieves stability, pain relief, correction of deformity or halting disease progression)

Purpose examplesUsed to relieve pain, provide stability, correct postural deformity from neurologic deficit, or halt advancing disease

Document updateDefinition updated in policy documentation (01/01/2026)

Interlaminar Lumbar Instrumented Fusion (ILIF) definition

DefinitionInterlaminar Lumbar Instrumented Fusion (ILIF): fusion procedure placing autograft or allograft bone between spinous processes and on remaining lamina with an implant inserted to stabilize and secure the spinous processes until fusion occurs

Procedure elements

Policy Summary

PayerUnitedHealthcare

PolicyInterspinous Fusion and Decompression Devices

Policy CodePolicy CS363.D

Change TypeDocumentation and definitional updatesevidence update

Effective DateJan 1, 2026

Next Review Date

Key ActionInclude the physician treatment plan with device type and level in medical records submitted for prior authorization reviews.

SourceLink

On This Page

Prior nonoperative therapy: Failure of at least 6 months of nonoperative treatment prior to consideration of the device.>= 6 months

Anatomic and stability limits: No more than 25° degenerative scoliosis and no more than Grade I degenerative spondylolisthesis; no dynamic instability at the operative level.scoliosis <=25°; spondylolisthesis <= Grade I

NASS 2025

Surgical suitability: Open decompressive surgery (e.g., laminectomy) is not a medically safe option because of comorbidities.

NASS 2025

Symptom relationSymptoms associated with neurogenic claudication should be relieved by lumbar flexion

Records should demonstrate failure of conservative therapy and document symptom pattern, imaging, and prior treatments.

Documentation Required

Medical Records Documentation Required

When medical records are required for prior authorization or claim review, include a physician treatment plan that specifies the intended device type and the spinal level(s) to be treated. Updated 01/01/2026: medical records documentation used for reviews now should include the physician treatment plan with device type and level.

Include physician treatment plan stating device type (static vs dynamic) and targeted level(s).
Include history, physical exam, imaging reports (MRI/CT), and documentation of nonoperative treatment and duration.

Denial Risk

Common Clinical Contraindications That May Trigger Denial

Be aware of common clinical contraindications and situations that may trigger denial. Cases that fall outside the policy’s qualifying criteria or have listed contraindications are not indicated and may be denied.

Degenerative spondylolisthesis Grade II or higher (≥ Grade II).
Degenerative scoliosis greater than 25°.
Dynamic instability at the operative level.
Symptoms not relieved by lumbar flexion or primarily axial back pain unrelated to activity.
Fixed motor deficit.
Patient medically suitable for direct decompression (e.g., laminectomy) — if suitable, static device not indicated.
BMI ≥ 40.
Prior lumbar surgery at the intended level.

Note

Evidence Limitations and Clinical Guidance

Evidence is limited and comparative effectiveness versus standard decompression or fusion is uncertain. Clinicians should consider the current evidence limitations and the need for larger, long-term trials; interspinous decompression and interlaminar stabilization systems without fusion are considered unproven/not medically necessary for treatment of spine pain or spinal stenosis outside of defined criteria.

Existing randomized trials are small to moderate; meta-analyses show no superiority of IPD versus decompression for pain or function.
Consider enrolling patients in clinical trials when appropriate and when device use is outside well-supported indications.
Interspinous fixation (fusion) devices remain medically necessary only when performed per FDA labeling and policy criteria.

Incision in lower back, opening through ligaments to access spinous processes, decompression of compressive elements as needed, placement of bone graft and implant

Document updateDefinition updated in policy documentation (01/01/2026)

Interlaminar Stabilization Device definition

DefinitionInterlaminar Stabilization Device: implantable interspinous process device intended to provide symptomatic relief of claudicatory lumbar spinal stenosis by reducing lumbar extension while preserving other motions

Example device descriptionU-shaped titanium implant inserted horizontally between adjacent spinous processes with serrated wings crimped over bone to hold the implant; typically implanted after decompression

Motion effectsDesigned to reduce extension while preserving flexion, axial rotation, and lateral bending

Interspinous Fixation Devices definition

DefinitionInterspinous Fixation Devices: devices intended for attachment to the spinous processes to achieve stabilization and promote bony fusion in patients with degenerative disc disease

Use contextTypically used as adjuncts to lumbar fusion procedures to provide posterior stabilization and promote arthrodesis

Distinguishing featureAffixed to spinous processes with goal of fusion (vs. decompressive spacers that distract without fusion)

Interspinous Process Decompression (IPD) definition

DefinitionInterspinous Process Decompression (IPD): minimally invasive procedure implanting a spacer between adjacent spinous processes to distract the neural foramen and decompress nerves (device expanded/opened after implantation)

MechanismSpacers implanted midline between lamina and spinous processes to provide dynamic stabilization and block stenosis-related lumbar extension

Indication contextUsed to treat lumbar spinal stenosis when conservative measures have failed

Lumbar Spinal Stenosis (LSS) definition

DefinitionLumbar Spinal Stenosis (LSS): narrowing or constriction of the lumbar spinal canal that may result in painful compression of a nerve and/or its blood supply

Clinical consequenceCan produce neurogenic claudication, leg and/or back pain due to neural element compression

Diagnostic basisAssessed by clinical presentation and advanced imaging (MRI/CT)

Neurogenic Claudication definition (short)

DefinitionNeurogenic Claudication: leg, buttock, or thigh pain or weakness related to lumbar spinal stenosis that is relieved by change in position (particularly lumbar flexion) or rest

Key clinical featureSymptoms improve with forward flexion or sitting and worsen with standing/extension

DifferentiateShould be differentiated from vascular claudication clinically

Interlaminar Stabilization Device / Interspinous device (updated definition)

Updated definitionInterlaminar Stabilization Device / Interspinous device: implantable devices placed between spinous processes to provide indirect decompression or posterior stabilization; may be static or dynamic and used with or without fusion

Static vs dynamicStatic (nonflexible/noncompressible) devices provide indirect decompression; dynamic devices are intended by FDA labeling to be used with direct decompression

Use contextsMay be used to provide symptomatic relief of claudicatory LSS or as adjunct stabilization with fusion depending on device labeling and clinical criteria

Arthrodesis / ILIF (updated definition)

Updated definitionArthrodesis / ILIF: surgical fusion procedures to achieve bony union of lumbar spinal segments; ILIF places graft and implant between spinous processes and lamina and secures spinous processes until fusion occurs

Clinical roleUsed to eliminate motion at a spinal segment to provide stability, relieve pain, or correct deformity; definitions updated in policy (01/01/2026)

Relation to devicesInterspinous fixation devices may be used to promote arthrodesis in the context of ILIF or other fusion techniques

Neurogenic Claudication (expanded definition)

Expanded definitionNeurogenic Claudication: clinical syndrome of lumbar spinal stenosis characterized by leg, buttock, or thigh pain and functional limitation that is typically relieved by lumbar flexion and positional changes

Functional criteria referencedPolicy references functional thresholds such as ability to sit ≥50 minutes and walk ≥50 feet as part of qualifying criteria for some interspinous devices

Clinical differentiationDifferentiate from vascular claudication; symptoms often posture-dependent and improve with forward flexion